摘要:
There is provided a heptamer-type small guide nucleic acid that comprises any of the 7-base sequences of SEQ ID NOS: 1 to 15, and induces apoptosis of human leukemia cells. A leukemia therapeutic agent containing the heptamer-type small guide nucleic acid as an active ingredient is also provided. The novel heptamer-type sg nucleic acid can induce apoptosis of human leukemia cells.
摘要翻译:提供了包含SEQ ID NO:1至15的任何7-碱基序列的七聚体型小导向核酸,并诱导人白血病细胞的凋亡。 还提供含有七聚体型小引导核酸作为有效成分的白血病治疗剂。 新型七聚体型sg核酸可诱导人白血病细胞凋亡。
摘要:
There is provided a heptamer-type small guide nucleic acid that comprises any of the 7-base sequences of SEQ ID NOS: 1 to 15, and induces apoptosis of human leukemia cells. A leukemia therapeutic agent containing the heptamer-type small guide nucleic acid as an active ingredient is also provided. The novel heptamer-type sg nucleic acid can induce apoptosis of human leukemia cells.
摘要:
As a molecular material for synthesizing a protein-encoding polynucleotide via reverse translation from the protein, a reverse translation-mediating oligonucleotide having the following properties (a) to (d) is provided: (a) containing a nucleotide sequence “nnn” encoding an amino acid residue “Xaa”; (b) the nucleotide sequence “nnn” being separable; (c) containing a nucleotide sequence binding to the amino acid residue “Xaa”; and (d) not containing any nucleotide sequence binding to an amino acid residue other than the amino acid residue “Xaa”. Also, a method of synthesizing a polynucleotide encoding the amino acid sequence of the primitive protein via a reverse translation reaction with the above oligonucleotide is provided.